Scriptids

Investor pitch

Scriptids

Medication access without the runaround—plain-language Scripti answers, prior-auth prediction, and clinic workflows that clear the path to the pharmacy counter.

See the marketFunding ask

Seed round · $2.5M · Projections are illustrative

The problem

Patients stall. Clinics drown in paperwork. Pharmacies wait.

Prior authorization and opaque insurance rules delay starts of therapy. Consumers lack plain-language help; clinics burn staff hours on forms that should already know the answer.

  • Hours lost

    Staff time on PA chase-downs every week

  • Delayed starts

    Patients leave the pharmacy empty-handed

  • Opaque coverage

    No clear next step until the claim fails

The product

One stack for consumers and clinics

Scripti explains symptoms and prescriptions in plain language. Prior-auth tools predict friction, autofill forms, and suggest covered alternatives. Clinic SaaS turns that into a daily workflow.

  1. 01

    Scripti

    Consumer Q&A that builds confidence before the visit or pickup.

  2. 02

    Prior auth

    Likelihood signals, optimizer autofill, and alternative drugs.

  3. 03

    Clinic SaaS

    Seats, case fees, and dashboards for high-volume practices.

Market

A massive medication-access market

We focus where paperwork and confusion block therapy—then expand with partner pharmacies and clinic groups.

TAM

$48B

U.S. digital medication access: prior-auth automation, pharmacy workflows, and consumer Rx education.

SAM

$6.2B

Clinics and consumers adopting SaaS for PA prediction, form automation, and plain-language Scripti guidance.

SOM

$180M

Five-year reachable share via clinic SaaS seats, consumer Plus plans, and partner pharmacy referrals.

Traction plan

Projected monthly active users

Free Explorer + Scripti Plus funnels feed clinic land-and-expand. Target Y5: 1.5M MAU.

Y1 MAU
25K
Y3 MAU
450K
Y5 MAU
1.5M

Projected earnings

Revenue ramp to $48M

Mix of consumer subscriptions (Scripti Plus, Prior auth Plus, Complete) and clinic SaaS (platform fee + per-case PA fees).

YearRevenuePaying usersClinic accounts
Y1$420K1,80040
Y2$2.1M9,500180
Y3$8.5M38,000620
Y4$22M95,0001,400
Y5$48M210,0002,800

The raise

Funding goal: $2.5M

Seed capital to harden the product, win clinic pilots, and ship compliance-ready infrastructure for medication-access workflows.

Seed round

$2.5M

~18–24 months of runway to reach product-market fit in clinics and meaningful consumer Plus conversion.

  • Clinic land-and-expand playbook
  • Scripti + PA quality loop
  • Partner pharmacy distribution

How funds are distributed

  • Product & engineering40% · $1M

    PA optimizer, Scripti quality, clinic dashboard, and core reliability.

  • Go-to-market25% · $625K

    Clinic pilots, consumer acquisition, and pharmacy partnership growth.

  • Clinical, compliance & security15% · $375K

    HIPAA-ready controls, clinical review, and audit readiness.

  • Operations & G&A10% · $250K

    Support, legal, finance, and infrastructure.

  • Runway reserve10% · $250K

    Buffer for hiring lag, model costs, and unexpected compliance work.

The ask

Join us in clearing the path to every prescription

We're raising $2.5M to scale Scriptids from early product to category-defining medication-access infrastructure.

Goal
$2.5M
TAM
$48B
Y5 MAU
1.5M
Y5 revenue
$48M
Talk with the teamView pricing model

Figures are forward-looking estimates for discussion—not guarantees of future performance. Not medical advice.